Hypothesis Comparison

⚛ Collide these ⚔ Judge as Duel

Comparing 2 hypotheses side-by-side

|

APOE isoform modifies the C1q binding landscape, biasing C1q toward inflammatory

APOE,C1QA,C1QB,C1QC,TREM2,APP · neurodegeneration · -
Composite
0.590
Price
$0.55
Evidence For
0
Evidence Against
0

This is best treated as a stratification and response-modifier hypothesis rather than a primary C1q mechanism. APOE4 may alter lipid and aggregate surfaces in ways that shift C1q interactomes toward complement-amplifying complexes, but the causal chain remains loose because ApoE biology is highly pleiotropic.

Selective blockade of classical-pathway activation downstream of C1q will reduce

C1QA,C1QB,C1QC,C1R,C1S,C4A,C4B,C3 · neurodegeneration · -
Composite
0.750
Price
$0.60
Evidence For
0
Evidence Against
0

The most actionable synthesis is that pathogenicity may depend more on conversion of C1q binding into classical-pathway protease activity than on C1q recognition alone. In this model, inhibiting C1r/C1s should attenuate C4/C3-mediated synapse loss and neuroinflammation while preserving some homeostatic debris sensing and cargo recognition by C1q.

Convergent vs Divergent Predictions

This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.

C1QAC1QBC1QCNeuroinflammationneurodegeneration
Convergent signals
  • C1QA recurs across 2 selected hypotheses with aligned directionality in neuroinflammation.
  • C1QB recurs across 2 selected hypotheses with aligned directionality in neuroinflammation.
  • C1QC recurs across 2 selected hypotheses with aligned directionality in neuroinflammation.
Divergent signals
  • No direct polarity conflicts detected among the selected hypotheses.

Verdict Summary

2/11
dimensions won
APOE isoform modifies the C1q binding la
10/11
dimensions won
Selective blockade of classical-pathway

Radar Chart — 10 Dimensions

Score Comparison Bars

Mechanistic
0.68
0.79
Evidence
0.55
0.74
Novelty
0.67
0.58
Feasibility
0.67
0.86
Impact
0.57
0.88
Druggability
0.48
0.91
Safety
0.49
0.62
Competition
0.52
0.63
Data
0.69
0.77
Reproducible
0.54
0.72
KG Connect
0.50
0.50

Score Breakdown

DimensionAPOE isoform modifies the C1q Selective blockade of classica
Mechanistic0.6800.790
Evidence0.5500.740
Novelty0.6700.580
Feasibility0.6700.860
Impact0.5700.880
Druggability0.4800.910
Safety0.4900.620
Competition0.5200.630
Data0.6900.770
Reproducible0.5400.720
KG Connect0.5000.500

Evidence

APOE isoform modifies the C1q binding landscape, biasing C1q

No evidence citations yet

Selective blockade of classical-pathway activation downstrea

No evidence citations yet

Debate Excerpts

APOE isoform modifies the C1q binding landscape, b

4 rounds · quality: 0.68

Persona-Theorist

1. **Synaptic C1q drives complement-dependent pruning, while microglial surface-associated C1q biases phagocyte state through receptor-specific signaling** **Mechanism:** C1q deposited on weak ...

Persona-Skeptic

Overall skeptical read: the debate is probably mixing three separable variables that have not been cleanly orthogonalized experimentally: `location`, `ligand identity`, and `receiver-cell state`. The ...

Persona-Domain Expert

**Triage** The ideas worth carrying forward are `6`, `5`, `1`, `2`, `4`, and `7`, in that order. I would drop `3` for now; it is too speculative to support a drug program. The main translational poi...

Persona-Synthesizer

{"ranked_hypotheses":[{"title":"Selective blockade of classical-pathway activation downstream of C1q will reduce synaptotoxic complement amplification while preserving beneficial C1q recognition funct...

Selective blockade of classical-pathway activation

4 rounds · quality: 0.68

Persona-Theorist

1. **Synaptic C1q drives complement-dependent pruning, while microglial surface-associated C1q biases phagocyte state through receptor-specific signaling** **Mechanism:** C1q deposited on weak ...

Persona-Skeptic

Overall skeptical read: the debate is probably mixing three separable variables that have not been cleanly orthogonalized experimentally: `location`, `ligand identity`, and `receiver-cell state`. The ...

Persona-Domain Expert

**Triage** The ideas worth carrying forward are `6`, `5`, `1`, `2`, `4`, and `7`, in that order. I would drop `3` for now; it is too speculative to support a drug program. The main translational poi...

Persona-Synthesizer

{"ranked_hypotheses":[{"title":"Selective blockade of classical-pathway activation downstream of C1q will reduce synaptotoxic complement amplification while preserving beneficial C1q recognition funct...

Price History Overlay

Knowledge Graph Comparison

APOE isoform modifies the C1q binding la

32 edges
Top Node Types
protein16
process5
gene3
pathway3
drug2
Top Relations
activates12
causes7
regulates2
mediates2
modulates2

Selective blockade of classical-pathway

32 edges
Top Node Types
protein16
process5
gene3
pathway3
drug2
Top Relations
activates12
causes7
regulates2
mediates2
modulates2